Slides
Page 1
Oslo, 27 August 2026 Q2 2026 ResultsMission-criticalsoftware Predictablebusiness
Page 2
The second quarter 2026 numbers in a nutshell 2 Specialised Healthcare Emergency Income55 MNOKEBITDA Margin22%Organic Growth Q/Q7% Income127 MNOKEBITDA Margin25%Organic Growth Q/Q9% Income71 MNOKEBITDA Margin28%Organic Growth Q/Q10% 56%44% The Specialised Healthcare business was established in 2008 and Emergency in 2015
Page 3
Specialised healthcare 3 Woman & Child Connected ImagingLIMS – Blood ManagementHealth Analytics Medication ManagementOmda supports specialised healthcare value chains through an ecosystem of different software solutions
Page 4
The Emergency value chain strengthened with PSS 4 Planning & Preparedness Calls & Dispatch On Scene Response Transport and Care Hospital Care Analysis & ImprovementOmda supports everystep of emergency response through an ecosystem of different software solutions
Page 5
The UK is becoming a key market 5 1 2 Montenegro Moldova Croatia UK annual sales1) 15% 2%1) Including Saab PSS business
Page 6
Second quarter 2026 performance 9%6 127 MNOKReported revenueOrganic growth Y/Y
Page 7
Profitable organic development 25%7 32 MNOKReported EBITDAReported EBITDA margin
Page 8
Revenue quality supports predictability 76%8 97 MNOKRecurring SW-revenueSW-Recurring share Professional Services 25 MNOK, ~90% recurring
Page 9
Predictability is built into the customer model 9 Embedded by designReliable by relation•Mission-critical daily workflows•Certified and deeply integrated products•Public-sector customer base•High cost and risk of switching •Long customer relationships•Repeatable profitable organic development•Recurring revenues•Focus on two principal markets
Page 10
Current Pro Forma Growth Outlook 2026-2027 10 0100200300400500600700800 2026 2027 Organic business Acquired business EBITDA28-32% EBITDA28-32%
Page 11
Guidance and growth ambitions (Proforma1)) 0 200 400 600 800 1000 1200 1400 202520262027202820292030Revenue BaseAcquired Revenue 11 ActualsGuidance Growth ambitions 1) 2025 is base. Constant currency. 5% organic growth and 15% acquired growth.
Page 12
•Expands Omda’s footprint in the UK public sector•Strengthens the offering across the emergency value chain•Adds around 75 employees •Expected closing Q4 2026•Recent proof point: –Additional contracts with customers: 60 MSEK…–… an estimated annual revenue base of more than 100 MSEK SaabPSSsharpens the Emergency business 12
Page 13
AI strengthens productivity 13 •Omda delivers certified software for mission-critical workflows•AI supports development, testing, documentation and service productivity•Q2 observation: Slightly lower capex•Long-term ambition: lower capitalised development as a share of revenue
Page 14
Capital allocation: lower cost, greater capacity•Exploring refinancing of the bond (OMDA-02 PRO)•Objective: –Lower interest cost and increase strategic capacity•Investment remains focused on–Targeted acquisitions–Add-ons to customers–AI-enabled productivity•Disciplined Build vs Buy business cases remains the governing principle 14
Page 15
The long-term Omda model 15 •Organic growth 5–10%•Acquired growth 10–20% per year•EBITDA above 30% over time•Capitalised development from approximately 10% towards 5% of revenue•Portfolio centred on Emergency and Specialised Healthcare•Growth funded through cash flow and disciplined leverage
Page 16
The trend is as important as the Q2 2026 predictability 0%5%10%15%20%25%30% Q2-24Q2-25Q2-26EBITDA MarginEBITDAC Margin16
Page 17
What Q2 adds to the Omda story•Predictable and profitable organic development•The transformational Saab PSS acquisition was signed•A clearer portfolio centred on two principal markets•AI and disciplined product investment support scalable growth•2026 guidance and long-term ambitions reiterated 17
Page 18
The way forward 18
Page 19
19 Q&A